Accelerating breakthrough discoveries into medicines, affiliated with The #HarringtonProject. #impinv #drugdevelopment #biotech #CLE

Cleveland, OH
Joined November 2017
Congratulations to Leen Adjalouni for making the Crain's 2020 Twenty in their 20s list #CRAINS20CLE #clevelandtalent
Introducing Crain’s 2020 Twenty in their 20s -- Here you’ll find the typical roll call of accomplishments beyond their years, impressive feats of leadership, advocates, healers and entrepreneurs | Read more: ow.ly/9rLY50A83tF #CRAINS20CLE
1
Great read - Cleveland can and must do better
Letter from the publisher, @McIntyreCrains: Yes, we can — and must — do better on diversity ow.ly/eH1250A862f
1
Congratulations to the Amphista Therapeutics team on their recent appointment of Dr. Ian Churcher, an internationally recognized leader in the field of targeted protein degradation, as Chief Scientific Officer. Read more here: bit.ly/3e8W2PU #CSO #cancertherapeutics
Congrats to @athersys on their public offering of $57M! Proud to be a part of the #CLE #Biotech community @CrainsCleveland bit.ly/34YyWZe
2
FDA authorizes #Athersys to initiate a pivotal clinical trial evaluating #MultiStem Cell Therapy in patients with #COVID19 induced #ARDS. businesswire.com/news/home/2…
8
47
10
107
Excited to announce our investment in @AmphistaTherapeutics alongside Advent Life Sciences. Amphista Therapeutics is a biopharmaceutical company with a novel targeted protein degradation platform. Read more here: bit.ly/2V88FTM
3
We are excited to announce The Harrington Discovery Institute at @UHhospitals launched a five-part initiative to accelerate near-term therapies for treating Coronavirus and future pandemic threats. Learn more here: bit.ly/3e1MzuO
2
Advising a #COVID19 research initiative for #socialimpact. Your #COVID19 experience as a patient or caregiver can make a difference. Join the Study Covid Project (studycovid.org) to help leaders make smarter decisions. @fastercures @metrohealthCLE @diabetesdaily
2
2
A COVID-19 (coronavirus) vaccine is in development - but what’s the process and when will it be available? Dr. Robert Salata, Program Director, UH Roe Green Center for Travel Medicine & Global Health, explains. #COVID19 #coronavirus
5
9
2
21
Help #CLE’s most vulnerable by contributing to the Greater #Cleveland #COVID19 Rapid Response Fund today: bit.ly/CLEgives. #CLEresponds #COVID19OhioReady
9
10
#KoutifTherapeutics, one of our portfolio companies, received $250,000 in grant funding from the Crohn's & Colitis Foundation to support the development of novel small molecule therapeutics for the treatment of #IBD and #Crohnsdisease. Read more here: bit.ly/37596lt
4
BioMotiv, associated with #TheHarringtonProject, and Bristol-Myers Squibb launch their first #biotech after the announcement of their partnership, Anteros Pharmaceuticals, focused on developing new class of drugs for #fibrotic and #inflammatorydiseases. bit.ly/2SkVVrc
2
One of our portfolio companies, Aro Biotherapeutics recently announced a licensing and collaboration agreement with a top tier pharmaceutical company, Ionis Pharmaceuticals – the leader in RNA based therapeutics. Read more here: bit.ly/2teGvMS
BioMotiv and Atomwise announced a strategic collaboration today to integrate AI technology, drug development expertise and an ecosystem of partners for the commercialization of promising early-stage research: bit.ly/35QbSup
1
4
8
There are approximately 100,000 patients with #retinitispigmentosa living in the US, but there is no cure for the disease. #OptiKira is developing compounds that would slow progression of the disease: OptiKira.com @fightblindness @arixbioscience @CRiverLabs
1
#SapVax is developing a novel cancer vaccine platform that has the potential to be used in combination with other #immunooncology drugs, including #checkpointinhibitors and #neoantigens. Learn more: sapvaxllc.com @BrimbleM
1
3